News of Note—Ebola, flu vaccines and more

In this week's news of note, health officials have experienced issues with the Ebola vaccine rollout in the Democratic Republic of Congo. (Pixabay)

The Ebola vaccine rollout has experienced some hiccups in the Democratic Republic of Congo. AFP story

Australia is seeing a shortage of flu vaccines due to high demand. Sydney Morning Herald story

A charity has sued U.K. health secretary Jeremy Hunt claiming sex discrimination over the government's decision not to provide HPV vaccines to boys. Daily Mail story

Whitepaper

Simplify and Accelerate Drug R&D With the MarkLogic Data Hub Service for Pharma R&D

Researchers are often unable to access the information they need. And, even when data does get consolidated, researchers find it difficult to sift through it all and make sense of it in order to confidently draw the right conclusions and share the right results. Discover how to quickly and easily find, synthesize, and share information—accelerating and improving R&D.

Suggested Articles

Merck just last month won the world's first licensure for an Ebola vaccine. Now, an international group authorized funding to establish a stockpile.

GSK expects Shingrix supplies to rise slightly in 2020, but the real "step change" will come in 2024 with a brand-new manufacturing facility.

Ebola has claimed thousands of lives in recent outbreaks, but now the world has a licensed vaccine option in Merck's Ervebo.